Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002064832-25-000067
Filing Date
2025-12-05
Accepted
2025-12-05 18:47:53
Documents
1
Period of Report
2025-12-05

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 4125
  Complete submission text file 0002064832-25-000067.txt   5564
Mailing Address 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address 4 KINGSBURY AVENUE WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Issuer) CIK: 0001177648 (see all company filings)

EIN.: 043205099 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ENANTA PHARMACEUTICALS, INC. 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address
Trout Harry R. III (Reporting) CIK: 0002085123 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35839 | Film No.: 251554219